| - GRCh37:
- Chr14:77923430
- GRCh38:
- Chr14:77457087
| VIPAS39 | | Arthrogryposis, renal dysfunction, and cholestasis 2 | Likely benign (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:77900223
- GRCh38:
- Chr14:77433880
| VIPAS39 | R381*, R286*, R301*, R332*, R336*, R350*, R370* | Arthrogryposis, renal dysfunction, and cholestasis 2 | Pathogenic (Aug 18, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr14:77919659-77919661
- GRCh38:
- Chr14:77453316-77453318
| VIPAS39 | | Arthrogryposis, renal dysfunction, and cholestasis 2 | Pathogenic (Aug 18, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr14:77909019
- GRCh38:
- Chr14:77442676
| VIPAS39 | | Arthrogryposis, renal dysfunction, and cholestasis 2, not provided | Benign/Likely benign (Jun 15, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:77894808
- GRCh38:
- Chr14:77428465
| VIPAS39 | D456N, D407N | Arthrogryposis, renal dysfunction, and cholestasis 2 | Uncertain significance (Nov 18, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr14:77901646
- GRCh38:
- Chr14:77435303
| VIPAS39 | T286A, T335A | Arthrogryposis, renal dysfunction, and cholestasis 2 | Uncertain significance (Jun 8, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr14:77909466-77909467
- GRCh38:
- Chr14:77443123-77443124
| VIPAS39 | | Arthrogryposis, renal dysfunction, and cholestasis 2 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr14:77896106
- GRCh38:
- Chr14:77429763
| VIPAS39 | W395*, W346* | Arthrogryposis, renal dysfunction, and cholestasis 2 | Pathogenic (Sep 18, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr14:77908960
- GRCh38:
- Chr14:77442617
| VIPAS39 | H226R, H177R | Arthrogryposis, renal dysfunction, and cholestasis 2 | Likely pathogenic (Sep 18, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr14:77894719
- GRCh38:
- Chr14:77428376
| VIPAS39 | S485R, S436R | not provided, Arthrogryposis, renal dysfunction, and cholestasis 2 | Conflicting interpretations of pathogenicity (Dec 31, 2019) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr14:77914847
- GRCh38:
- Chr14:77448504
| VIPAS39 | R165Q, R116Q | Arthrogryposis, renal dysfunction, and cholestasis 2, not provided | Uncertain significance (Oct 21, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:77920444
- GRCh38:
- Chr14:77454101
| VIPAS39 | M1R | Arthrogryposis, renal dysfunction, and cholestasis 2 | Pathogenic (Apr 1, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr14:77902228
- GRCh38:
- Chr14:77435885
| VIPAS39 | Q291*, Q242* | Arthrogryposis, renal dysfunction, and cholestasis 2 | Pathogenic (Apr 1, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr14:77908979
- GRCh38:
- Chr14:77442636
| VIPAS39 | R220*, R171* | Arthrogryposis, renal dysfunction, and cholestasis 2 | Pathogenic (Apr 1, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr14:77907418-77907422
- GRCh38:
- Chr14:77441075-77441079
| VIPAS39 | T201fs, T250fs | Arthrogryposis, renal dysfunction, and cholestasis 2 | Pathogenic (Apr 1, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr14:77910654
- GRCh38:
- Chr14:77444311
| VIPAS39 | Q179*, Q130* | Arthrogryposis, renal dysfunction, and cholestasis 2 | Pathogenic (Apr 1, 2010) | no assertion criteria provided |